News
Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, ...
Hims & Hers Health has a better P/E ratio of 77.6 than the aggregate P/E ratio of 48.44 of the Health Care Providers & ...
Tesla ( TSLA) was the best-performing stock in the S&P 500 as the feud between CEO Elon Musk and President Donald Trump that ...
21h
Investor's Business Daily on MSNStock Market Rises Despite Musk-Trump Feud; CrowdStrike, Broadcom, Meta-Constellation Deal In Focus: Weekly ReviewT he stock market rally had a solid week, with the S&P 500 and Nasdaq trying to clear recent ranges. Elon Musk and President ...
20h
Investor's Business Daily on MSNThe Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results